Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore

Apollo Hospitals on Thursday reported a 76% year-on-year (YoY) jump in net profit to Rs 254 crore in Q4FY24, led by growth across the hospital, diagnostics, speciality and pharmacies businesses.

The company reported a net profit of Rs 145 crore in the corresponding quarter of the previous year.

Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24.


The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.

For the FY24, revenue grew 14% YoY to Rs. 9,867 crore and net profit rose 13% to 1.145 crore. The EBITDA margin declined 71 basis points to 23.88%.

The healthcare services business (hospital business) revenue grew 17% YoY to Rs 2,563 crore in Q4FY24. The EBITDA margins declined 122 basis points to 23.15%.

The occupancy stood at 65% in Q4FY24, while the average length of stay (ALOS) was 3.30. The average revenue per occupied bed (ARPOB) rose 12% to Rs 59,523.

The company said it is on track to add 2300 beds with Rs.3400 crs in the next three financial years.

Diagnostics and retail healthcare business grew 15% YoY to Rs.355 crore in Q4FY24. The EBITDA margins for the business rose 178 basis points YoY to 10.06% in Q4.

Apollo HealthCo - the digital healthcare and omni-channel pharmacy platform grew 13% YoY to 2,027 crore in Q4FY24.
The Apollo Health Co losses narrowed to Rs 18 crore in Q4FY24 from Rs 89 crore in Q4FY23.

As on March 31, 2024, Apollo Hospitals had 7,945 operating beds across the network (excluding AHLL & managed beds), out of which 2,557 were new with 1,603 occupied beds.

Apollo Hospitals said Shobana Kamineni has decided to relinquish as executive vice chairperson with immediate effect. She will continue to be a non-executive non-independent director on the Board of Apollo.

Kamineni will assume office as the executive chairperson of Apollo Health Co - the omni channel platform, where Apollo Hospitals owns 59.2% stake.

"Given the need to focus on successfully scaling up the business verticals of Apollo HealthCo including the omni digital healthcare platform Apollo 24x7 which requires my full-time attention," Kamineni said in her letter to the Board.

The company declared a final dividend of Rs 10 per share for FY24. It has earlier declared Rs 6 per share as interim dividend.